Seneschal Advisors’s Zoetis ZTS Stock Holding History

Seneschal Advisors’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$237	–	624
2026 Q1	$237	Hold	2	–	–	﹤0.01%	520
2025 Q4	$252	Sell	2 -2	-50%	-$261	﹤0.01%	500
2025 Q3	$586	Buy	+4	New	+$605	﹤0.01%	324

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Seneschal Advisors's ZTS Position: Q2 2026 in Review

Seneschal Advisors sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2 shares — an estimated $237 sold.

Seneschal Advisors first reported a position in ZTS in Q3 2025 and held it in 3 quarters. The position peaked at $586 in Q3 2025. 1,430 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

Seneschal Advisors reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
Seneschal Advisors sold 2 Zoetis shares in Q2 2026, an estimated $237.
Seneschal Advisors first reported a position in Zoetis in Q3 2025 and held it in 3 quarters.
Seneschal Advisors's Zoetis position peaked at $586 in Q3 2025.
1,430 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.